CORCEPT THERAPEUTICS INC — Net Income by Fiscal Year
27 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/96993e88-3975-4c81-a85d-26c306011070/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $99.7M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-011091 |
| FY 2024 | $141.2M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-008167 |
| FY 2023 | $106.1M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-005055 |
| FY 2022 | $101.4M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-005581 |
| FY 2021 | $112.5M | 2021-01-01 – 2021-12-31 | evidence 0001628280-22-002714 |
| FY 2020 | $106.0M | 2020-01-01 – 2020-12-31 | evidence 0001628280-21-002861 |
| FY 2019 | $94.2M | 2019-01-01 – 2019-12-31 | evidence 0001628280-20-002122 |
| FY 2018 | $75.4M | 2018-01-01 – 2018-12-31 | evidence 0001628280-19-001879 |
| FY 2017 | $129.1M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-003840 |
| FY 2016 | $8.1M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-003493 |
| FY 2015 | $-6.4M | 2015-01-01 – 2015-12-31 | evidence 0001088856-16-000011 |
| FY 2014 | $-31.4M | 2014-01-01 – 2014-12-31 | evidence 0001562762-15-000080 |
| FY 2013 | $-46.0M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-100313 |
| FY 2012 | $-38.0M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-110085 |
| FY 2011 | $-219.6M | 1998-05-13 – 2012-03-31 | evidence 0001193125-12-225895 |
| FY 2010 | $-26.0M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-112317 |
| FY 2009 | $-20.2M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-112317 |
| FY 2008 | $-20.1M | 2008-01-01 – 2008-12-31 | evidence 0001193125-12-112317 |
| FY 2007 | $-11.6M | 2007-01-01 – 2007-12-31 | evidence 0001193125-12-112317 |
| FY 2006 | $-24.9M | 2006-01-01 – 2006-12-31 | evidence 0001193125-12-112317 |
| FY 2005 | $-20.1M | 2005-01-01 – 2005-12-31 | evidence 0001193125-12-112317 |
| FY 2004 | $-15.5M | 2004-01-01 – 2004-12-31 | evidence 0001193125-12-112317 |
| FY 2003 | $-9.8M | 2003-01-01 – 2003-12-31 | evidence 0001193125-12-112317 |
| FY 2002 | $-18.5M | 2002-01-01 – 2002-12-31 | evidence 0001193125-12-112317 |
| FY 2001 | $-7.5M | 2001-01-01 – 2001-12-31 | evidence 0001193125-12-112317 |
| FY 2000 | $-1.8M | 2000-01-01 – 2000-12-31 | evidence 0001193125-12-112317 |
| FY 1999 | $-321.0k | 1998-05-13 – 1999-12-31 | evidence 0001193125-12-112317 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CORCEPT THERAPEUTICS INC — all facts · Revenue · Operating Income